PDCD1 and neoplasm: Interferon gamma (IFN‐γ) is a crucial nexus for controlling PD‐1‐mediated tumor infiltration by T cells,[17] so the increasement of IFN‐γ in Group C and Group E can expand the effect of anti‐PD‐L1 therapy in mice (Figure 5K).